References
- Sajjadi H, Paparella MM. Meniere’s disease. Lancet. 2008;372(9636):406–414.
- Densert O, Ingelstedt S, Ivarsson A, et al. Immediate restoration of basal sensorineural hearing (Mb Meniere) using a pressure chamber. Acta Otolaryngol. 1975;80(1–2):93–100.
- Densert B, Sass K. Control of symptoms in patients with Meniere’s disease using Middle ear pressure applications: two years follow-up. Acta Otolaryngol. 2001;121(5):616–621.
- Shojaku H, Watanabe Y, Mineta H, et al. Long-term effects of the Meniett device in Japanese patients with Meniere’s disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan. Acta Otolaryngol. 2011;131(3):277–283.
- Feldmann H. Tympanic membrane massage, origin and decline of a promising therapeutic concept. Laryngorhinootologie. 1996;75(8):491–498. German.
- Watanabe Y, Shojaku H, Junicho M, et al. Intermittent pressure therapy of intractable Meniere’s disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report. Acta Otolaryngol. 2011;131(11):1178–1186.
- Ikezono TI, Takeda A, Nakamura N, et al. Documents for standards in diagnostic criteria for dizziness. Equilib Res. 2017;76(3):233–241.
- Shojaku H, Aoki M, Takakura H, et al. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere’s disease and delayed endolymphatic hydrops: a prospective study. Acta Otolaryngol. 2021;141(10):907–914.
- Gürkov R, Filipe Mingas LB, Rader T, et al. Effect of transtympanic low-pressure therapy in patients with unilateral Menière’s disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial. J Laryngol Otol. 2012;126(4):356–362.
- Masuda K, Goto F, Fujii M, et al. Investigation of the reliability and validity of Dizziness Handicap Inventory (DHI) translated into Japanese. Equilibrium Res. 2004;63(6):555–563.
- Mizukoshi K, Watanabe Y, Shojaku H, et al. Preliminary guidelines for reporting treatment results in Menière’s disease conducted by the Committee of the Japanese Society for Equilibrium Research, 1993. Acta Otolaryngol Suppl. 1995;519:211–215.
- Odkvist LM, Arlinger S, Billermark E, et al. Effects of Middle ear pressure changes on clinical symptoms in patients with Meniere’s disease – a clinical multicentre placebo-controlled study. Acta Otolaryngol Suppl. 2000;543:99–101.
- Gates GA, Green JD, Jr, Tucci DL, et al. The effects of transtympanic micropressure treatment in people with unilateral Meniere’s disease. Arch Otolaryngol Head Neck Surg. 2004;130(6):718–725.
- Thomsen J, Sass K, Odkvist L, et al. Local overpressure treatment reduces vestibular symptoms in patients with meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol. 2005;26(1):68–73.
- Covelli E, Volpini L, Atturo F, et al. Delayed effect of active pressure treatment on endolymphatic hydrops. Audiol Neurotol. 2017;22(1):24–29.
- Russo FY, Nguyen Y, De Seta D, et al. Meniett device in Meniere disease: randomized, double-blind, placebo-controlled multicenter trial. Laryngoscope. 2017;127(2):470–475.
- Shojaku H, Takakura H, Asai M, et al. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable Meniere’s disease and delayed endolymphatic hydrops. Acta Otolaryngol. 2021;141(11):977–983.
- Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990;116(4):424–427.
- Enloe LJ, Shields RK. Evaluation of health-related quality of life in individuals with vestibular disease using disease-specific and general outcome measures. Phys Ther. 1997;77(9):890–903.
- Iwasaki S, Shojaku H, Murofushi T, et al. Diagnostic and therapeutic strategies for Meniere’s disease of the Japan Society for Equilibrium Research. Auris Nasus Larynx. 2021;48(1):15–22.